Ki-67 and bromodeoxyuridine labeling of human choroidal melanoma cells

References

• Gratzner H. Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474
   PubMed Web of Science ®Google Scholar
• Miyachi K. F., Fritzler M. J., Tan E. M. Autoantibody to nuclear antigen in proliferating cells. J. Immunol. 1978; 121: 2228–2234
   PubMed Web of Science ®Google Scholar
• Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar
• Gerdes J., Lemke H., Baisch H., Wacker H H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 1984; 133: 1710–1715
   PubMed Web of Science ®Google Scholar
• Barnard N. J., Hall P. A., Lemoine N. R., Kadar N. Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J. Pathol. 1987; 152: 287–295
   PubMed Web of Science ®Google Scholar
• Burger P. C., Shibata T., Kleihues P. The use of monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am. J. Surg. Pathol. 1986; 110: 611–617
   Google Scholar
• Giangaspero F., Doglioni C., Rivano M. T., Pilerei S., Gerdes J., Stein H. Growth fraction in human brain tumours defined by the monoclonal antibody Ki-67. Acta Neuropathol. 1987; 74: 179–182
   PubMed Web of Science ®Google Scholar
• Shibata T., Burger P. C., Kleihues P. Ki-67 immunoperoxidase stain as marker for the histological grading of nervous system tumours. Acta Neurochirurgica 1988; 43: 103–106
   Google Scholar
• Roggendorf W., Schuster T., Peiffer J. Proliferative potential of meningiomas determined with the monoclonal antibody K-67. Acta Neuropathol. [Berl] 1987; 73: 361–364
   PubMed Web of Science ®Google Scholar
• Van Erp P. E.J., De Mare S., Rijzewijk J. J., Van De Kerkhof P. CM., Bauer F. W. A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. Histochem. J. 1989; 21: 343–347
   PubMedGoogle Scholar
• Silvestrini R., Costa A., Veneroni S., Del Bino G., Persici P. Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet. 1988; 21: 123–131
   PubMedGoogle Scholar
• Kamel O., Franklin W. A., Ringus J., Meyer J. S. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am. J. Pathol. 1989; 134: 107–113
   PubMed Web of Science ®Google Scholar
• Char D. H., Huhta K., Waldman F. DNA cell cycle studies in uveal melanoma. Am. J. Ophthalmol. 1989; 107: 65–72
   PubMedGoogle Scholar
• Char D. H. DNA cell cycle studies in uveal melanoma. Tr. Am. Ophthalmol. Soc. 1988; 86: 561–580
   PubMedGoogle Scholar
• Vindelov L. L., Christensen I. J., Keiding N., Spang-Thomsen M., Nissen N. I. Long-term storage of samples for flow cytometric DNA analysis. Cytometry 1982; 3: 317–322
   Google Scholar
• Hoshino T., Nagashima T., Murovic J., Levin E. M., Levin V. A., Rupp S. M. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 1985; 6: 627–632
   PubMedGoogle Scholar
• Kindy-Degnan N., Char D. H., Swift P., Kaleta S., Ljung B.-M. Bromodeoxyuridine uptake in the assessment of hyperthermic therapy for intraocular tumor. Arch. Ophthalmol. 1989; 107: 746–750
   PubMedGoogle Scholar
• Char D. H., Crawford J. B., Kaleta S., Howes E. L., Lovato A. A., Quivey J. M. Analysis of radiation failure after uveal melanoma brachytherapy. Am. J. Ophthalmol. 1989; 108: 712–716
   PubMedGoogle Scholar
• Sasaki K., Murakami T., Kawasaki M., Takahashi N. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J. Cell. Physiol. 1987; 133: 579–584
   PubMed Web of Science ®Google Scholar
• Falini B., Canino S., Sacchi S., Ciani C., Martelli M. F., Gerdes J., Stein H., Pileri S., Gobbi M., Fagioli M. Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies. Br. J. Haematol. 1988; 69: 311–320
   PubMed Web of Science ®Google Scholar
• Morimura T., Kitz K., Budka H. In situ analysis of cell kinetics in human brain tumors. Acta Neuropathol. 1989; 77: 276–282
   PubMedGoogle Scholar
• Sasaki K., Matsumura K., Tsuji T., Shinozaki F., Takahasi M. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 1989; 62: 989–993
   Google Scholar
• Smolle J., Soyer H.-P., Kerl H. Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. Am. J. Dermatol. 1989; 11: 301–307
   Google Scholar
• Shibata T., Burger P. C., Kleihues P. Ki-67 immunoperoxidase stain as marker for the histological grading of nervous system tumours. Acta Neurochir. 1988; 43: 103–106, [suppl.]
   Google Scholar
• Augsburger J. J., Eagle R. C., Jr., Chiu M., Shields J. A. The effect of pre-enucleation radiotherapy on mitotic activity of choroidal and ciliary body melanomas. Ophthalmology 1987; 94: 1627–1630
   PubMedGoogle Scholar
• Char D. H., Phillips T. L., Andejeski Y., Crawford J. B., Kroll S. Failure of preenucleation radiation to decrease uveal melanoma mortality. Am. J. Ophthalmol. 1988; 106: 21–26
   PubMedGoogle Scholar
• van Dierendonck J. H., Keijzer R., van de Velde C. J.H., Cornelisse C. J. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res. 1989; 49: 2999–3006
   PubMed Web of Science ®Google Scholar